Skip Nav Destination
ISSN: 2666-2345
eISSN: 2590-017X
About this Journal
JIPO publishes high-quality manuscripts that appeal to a broad readership of healthcare professionals and scientists, especially those with an interest in oncology and immunology.
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature
Felipe Soto, Luis F. Torre-Sada, Frank E. Mott, Sang T. Kim, Roza Nurieva, Vickie R. Shannon, Saadia A. Faiz, Roberto F. Casal, Mehmet Altan, Julie Lin, Ajay Sheshadri
Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer
Mauro Di Pilato, Yun Gao, Yi Sun, Amina Fu, Carina Grass, Thomas Seeholzer, Regina Feederle, Irina Mazo, Samuel W. Kazer, Kevin Litchfield, Ulrich H. von Andrian, Thorsten R. Mempel, Russell W. Jenkins, Daniel Krappmann, Peter Keller
COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review
Juan I. Ruiz, Maria A. Lopez-Olivo, Yimin Geng, Maria E. Suarez-Almazor
Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
Zainab Fatima, Abdulrahman Abonofal, Bettzy Stephen
The Contemporary Landscape and Future Directions of Intratumoral Immunotherapy
Sebastian Brito-Orama, Rahul A. Sheth